Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.36B |
| 2 |
Tesla
TSLA
|
+$1.09B |
| 3 |
Amazon
AMZN
|
+$1B |
| 4 |
Microsoft
MSFT
|
+$963M |
| 5 |
Apple
AAPL
|
+$864M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.22B |
| 2 |
Bank of America
BAC
|
+$1.2B |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$381M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$294M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.44% |
| 2 | Technology | 25.75% |
| 3 | Financials | 6.27% |
| 4 | Consumer Discretionary | 5.79% |
| 5 | Industrials | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5001
Spero Therapeutics
SPRO
$60.6M
| $21.3K | ﹤0.01% |
9,625
-9,510
| -50% | -$24.9K |
2025 Q4
2 quarters
|
|
5002
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.68B
| $21K | ﹤0.01% |
520
-13,836
| -96% | -$566K |
2018 Q2
32 quarters
|
|
5003
Sohu.com
SOHU
$335M
| $20.9K | ﹤0.01% |
1,725
-418
| -20% | -$5.99K |
2013 Q2
52 quarters
|
|
5004
Nuveen New York Municipal Value Fund
NNY
$149M
| $20.9K | ﹤0.01% |
2,388
| – | – |
2022 Q4
14 quarters
|
|
5005
Organigram Holdings
OGI
$139M
| $20.8K | ﹤0.01% |
+20,438
| New | +$25K |
2026 Q2
0 quarters
|
|
5006
Artiva Biotherapeutics
ARTV
$205M
| $20.8K | ﹤0.01% |
+2,143
| New | +$19.5K |
2026 Q2
0 quarters
|
|
5007
Broadwind
BWEN
$66.5M
| $20.6K | ﹤0.01% |
+4,270
| New | +$14.1K |
2026 Q2
0 quarters
|
|
5008
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.9B
| $20.6K | ﹤0.01% |
440
+5
| +1% | +$234 |
2015 Q2
44 quarters
|
|
5009
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.65B
| $20K | ﹤0.01% |
400
| – | – |
2020 Q1
25 quarters
|
|
5010
Hain Celestial
HAIN
$12.2M
| $19.8K | ﹤0.01% |
35,352
-4,201
| -11% | -$3.12K |
2013 Q2
52 quarters
|
|
5011
Tamboran Resources
TBN
$1.03B
| $19.7K | ﹤0.01% |
607
+606
| +60,600% | +$21.7K |
2026 Q1
1 quarter
|
|
5012
iShares International Developed Real Estate ETF
IFGL
$80.4M
| $19.7K | ﹤0.01% |
882
| – | – |
2025 Q3
3 quarters
|
|
5013
Genius Group
GNS
$21.9M
| $19.7K | ﹤0.01% |
105,157
+103,186
| +5,235% | +$28.4K |
2025 Q4
2 quarters
|
|
5014
CALL
Valaris Ltd Warrants
VAL.WS
$899M
| $19.3K | ﹤0.01% |
2,303
| – | – |
2021 Q2
20 quarters
|
|
5015
Standard BioTools
LAB
$241M
| $19.3K | ﹤0.01% |
23,402
-7,892
| -25% | -$7.46K |
2023 Q3
11 quarters
|
|
5016
Valhi
VHI
$419M
| $19.2K | ﹤0.01% |
1,312
+1,011
| +336% | +$14.3K |
2013 Q2
52 quarters
|
|
5017
Fresenius Medical Care
FMS
$12B
| $19.2K | ﹤0.01% |
850
-638
| -43% | -$14.3K |
2013 Q2
52 quarters
|
|
5018
WhiteHawk Minerals Corp
WHK
$669M
| $18.8K | ﹤0.01% |
+674
| New | +$18.3K |
2026 Q2
0 quarters
|
|
5019
HawkEye 360 Inc
HAWK
$1.34B
| $18.6K | ﹤0.01% |
+918
| New | +$25.4K |
2026 Q2
0 quarters
|
|
5020
Pearson
PSO
$10.4B
| $18.5K | ﹤0.01% |
1,166
+169
| +17% | +$2.5K |
2013 Q2
52 quarters
|
|
5021
CALL
Lifezone Metals Ltd Warrants
LZM.WS
$5.01M
| $18.4K | ﹤0.01% |
45,000
| – | – |
2023 Q3
11 quarters
|
|
5022
Franklin FTSE Japan ETF
FLJP
$4.23B
| $18.4K | ﹤0.01% |
462
+318
| +221% | +$12.3K |
2026 Q1
1 quarter
|
|
5023
Angel Studios
ANGX
$646M
| $18.4K | ﹤0.01% |
5,000
| – | – |
2025 Q3
3 quarters
|
|
5024
Mobia Medical
MOBI
$335M
| $18.3K | ﹤0.01% |
+1,367
| New | +$17.7K |
2026 Q2
0 quarters
|
|
5025
iShares MSCI India Small-Cap ETF
SMIN
$685M
| $18.2K | ﹤0.01% |
257
+128
| +99% | +$8.53K |
2023 Q3
11 quarters
|
|
Similar funds
Citigroup's Q2 2026 Portfolio in Review
As of Q2 2026, Citigroup held 6,442 positions worth $303B, up 29% from $235B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup deployed $27.6B of net new capital in Q2 2026, opening 555 new positions and adding to 3,283 existing holdings. Its largest new stake was Honeywell Aerospace: 579,875 shares worth $128M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 45% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.22B trimmed.
- Citigroup's largest Q2 2026 buy was Honeywell Aerospace: 579,875 shares worth $128M.
- Citigroup added most to NVIDIA in Q2 2026, an estimated $2.36B increase.
- Citigroup's biggest Q2 2026 reduction was iShares Russell 2000 ETF, cutting an estimated $1.22B.
- Citigroup fully exited Sealed Air in Q2 2026, selling an estimated $111M.
- Citigroup's ten largest holdings make up 20% of its $303B portfolio in Q2 2026.
- Citigroup opened 555 new positions and closed 760 in Q2 2026.
- Citigroup's portfolio value rose 29% quarter-over-quarter to $303B.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.